USD 0.15
(-1.21%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 196 Thousand USD | 0.51% |
2022 | 195 Thousand USD | -14.1% |
2021 | 227 Thousand USD | -18.64% |
2020 | 279 Thousand USD | 18.47% |
2019 | 235.5 Thousand USD | 40.0% |
2018 | 168.22 Thousand USD | -7.96% |
2017 | 182.76 Thousand USD | 12.8% |
2016 | 162.03 Thousand USD | 1.07% |
2015 | 160.31 Thousand USD | -1.92% |
2014 | 163.45 Thousand USD | -76.42% |
2013 | 693.09 Thousand USD | 9.91% |
2012 | 630.57 Thousand USD | 4.03% |
2011 | 606.14 Thousand USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 191 Thousand USD | -2.05% |
2024 Q1 | 195 Thousand USD | -0.51% |
2023 Q4 | 196 Thousand USD | 6.52% |
2023 Q2 | 189 Thousand USD | -2.07% |
2023 FY | 196 Thousand USD | 0.51% |
2023 Q3 | 184 Thousand USD | -2.65% |
2023 Q1 | 193 Thousand USD | -1.03% |
2022 Q2 | 192 Thousand USD | -9.43% |
2022 Q3 | 191 Thousand USD | -0.52% |
2022 Q4 | 195 Thousand USD | 2.09% |
2022 FY | 195 Thousand USD | -14.1% |
2022 Q1 | 212 Thousand USD | -6.61% |
2021 Q3 | 234 Thousand USD | -0.85% |
2021 Q4 | 227 Thousand USD | -2.99% |
2021 Q1 | 231 Thousand USD | -17.2% |
2021 FY | 227 Thousand USD | -18.64% |
2021 Q2 | 236 Thousand USD | 2.16% |
2020 Q4 | 279 Thousand USD | 34.37% |
2020 Q1 | 221.11 Thousand USD | -6.11% |
2020 FY | 279 Thousand USD | 18.47% |
2020 Q2 | 217.87 Thousand USD | -1.46% |
2020 Q3 | 207.63 Thousand USD | -4.7% |
2019 FY | 235.5 Thousand USD | 40.0% |
2019 Q1 | 252.25 Thousand USD | 49.96% |
2019 Q3 | 211.46 Thousand USD | -8.66% |
2019 Q4 | 235.5 Thousand USD | 11.37% |
2019 Q2 | 231.52 Thousand USD | -8.22% |
2018 FY | 168.22 Thousand USD | -7.96% |
2018 Q4 | 168.22 Thousand USD | -3.03% |
2018 Q3 | 173.48 Thousand USD | 1.04% |
2018 Q2 | 171.69 Thousand USD | -4.3% |
2018 Q1 | 179.42 Thousand USD | -1.83% |
2017 Q1 | 170.15 Thousand USD | 5.01% |
2017 Q2 | 178.18 Thousand USD | 4.72% |
2017 FY | 182.76 Thousand USD | 12.8% |
2017 Q3 | 176.87 Thousand USD | -0.74% |
2017 Q4 | 182.76 Thousand USD | 3.33% |
2016 Q3 | 166.45 Thousand USD | 2.76% |
2016 FY | 162.03 Thousand USD | 1.07% |
2016 Q4 | 162.03 Thousand USD | -2.66% |
2016 Q2 | 161.99 Thousand USD | -1.58% |
2016 Q1 | 164.59 Thousand USD | 2.67% |
2015 Q4 | 160.31 Thousand USD | -0.17% |
2015 FY | 160.31 Thousand USD | -1.92% |
2015 Q3 | 160.58 Thousand USD | -3.64% |
2015 Q2 | 166.64 Thousand USD | 6.78% |
2015 Q1 | 156.06 Thousand USD | -4.52% |
2014 Q4 | 163.45 Thousand USD | -74.92% |
2014 Q1 | 685.18 Thousand USD | -1.14% |
2014 Q2 | 698.37 Thousand USD | 1.92% |
2014 FY | 163.45 Thousand USD | -76.42% |
2014 Q3 | 651.71 Thousand USD | -6.68% |
2013 Q3 | 680.82 Thousand USD | 2.79% |
2013 Q2 | 662.32 Thousand USD | 3.16% |
2013 Q4 | 693.09 Thousand USD | 1.8% |
2013 Q1 | 642.04 Thousand USD | 101718.34% |
2013 FY | 693.09 Thousand USD | 9.91% |
2012 Q3 | 604.56 Thousand USD | 1.43% |
2012 Q1 | 625.83 Thousand USD | 3.25% |
2012 Q2 | 596.06 Thousand USD | -4.76% |
2012 FY | 630.57 Thousand USD | 4.03% |
2012 Q4 | 630.58 USD | -99.9% |
2011 Q4 | 606.14 Thousand USD | -3.16% |
2011 FY | 606.14 Thousand USD | 0.0% |
2011 Q3 | 625.9 Thousand USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Akoya Biosciences, Inc. | 75.25 Million USD | 99.74% |
AngioDynamics, Inc. | 3.93 Million USD | 95.024% |
AtriCure, Inc. | 60.59 Million USD | 99.677% |
Avinger, Inc. | - USD | -Infinity% |
Azenta, Inc. | 60.43 Million USD | 99.676% |
BioLife Solutions, Inc. | 18.31 Million USD | 98.93% |
The Cooper Companies, Inc. | 2.52 Billion USD | 99.992% |
Daxor Corporation | 755.65 Thousand USD | 74.062% |
Ekso Bionics Holdings, Inc. | 4.83 Million USD | 95.944% |
Femasys Inc. | 4.25 Million USD | 95.397% |
Harvard Bioscience, Inc. | 30.7 Million USD | 99.362% |
Hologic, Inc. | 2.49 Billion USD | 99.992% |
ICU Medical, Inc. | 1.57 Billion USD | 99.988% |
Intuitive Surgical, Inc. | -82.1 Million USD | 100.239% |
KORU Medical Systems, Inc. | 3.65 Million USD | 94.634% |
LeMaitre Vascular, Inc. | 16.62 Million USD | 98.821% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Masimo Corporation | 871.7 Million USD | 99.978% |
Microbot Medical Inc. | 40 Thousand USD | -390.0% |
Meihua International Medical Technologies Co., Ltd. | 4592.00 USD | -4168.293% |
Merit Medical Systems, Inc. | 823.01 Million USD | 99.976% |
Nephros, Inc. | 1.39 Million USD | 85.899% |
NovoCure Limited | 596.24 Million USD | 99.967% |
NEXGEL, Inc. | 513 Thousand USD | 61.793% |
NEXGEL, Inc. | 513 Thousand USD | 61.793% |
Singular Genomics Systems, Inc. | 67.52 Million USD | 99.71% |
OraSure Technologies, Inc. | 11.38 Million USD | 98.279% |
Pro-Dex, Inc. | 7.53 Million USD | 97.399% |
Pulse Biosciences, Inc. | 8.08 Million USD | 97.576% |
Predictive Oncology Inc. | 2.18 Million USD | 91.046% |
Precision Optics Corporation, Inc. | 1.93 Million USD | 89.886% |
QuidelOrtho Corporation | 2.27 Billion USD | 99.991% |
Repligen Corporation | 510.14 Million USD | 99.962% |
Sanara MedTech Inc. | 9.11 Million USD | 97.849% |
STAAR Surgical Company | 31.46 Million USD | 99.377% |
Sharps Technology, Inc. | - USD | -Infinity% |
Utah Medical Products, Inc. | 295 Thousand USD | 33.559% |
DENTSPLY SIRONA Inc. | 1.79 Billion USD | 99.989% |
Jin Medical International Ltd. | - USD | -Infinity% |